UMU logo

Two projects at Umeå University receive funding in international collaborations with the aim to stop antimicrobial resistant bacteria

VH portraitMIMS and UCMR Researchers are funded by the Swedish Research Council for their participation in International research collaborations in two research consortia funded within the European Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). These are the only pojects that are funded in Sweden in this call.

[2018-10-30] MIMS Group Leader and UCMR Researcher Vasili Hauryliuk, Department of Molecular Biology, is part of the project “Development of novel ribosome-targeting antibiotics” with collaborators in Germany, France, Czech Republic and Italy. Under the lead of Daniel Wilson at the University of Hamburg, Germany, the collaborating laboratories will focus on discovering novel antibiotics which are targeted towards the ribosome, the cellular protein fabric, which is one of the major target of existing antibiotics.

Three work packages will develop different types of novel antibiotics with improved activity and selectivity. All of them will have different chemical scaffolds that target novel sites on the ribosome and different steps of the translation cycle, the synthesis of bacterial proteins.

The multidisciplinary consortium will have focus on the development of novel antibiotics against Mycobacterium tuberculosis and Priority 1 pathogens. The latter are bacteria which have become resistant to a large number of antibiotics and the best available antibiotics for treating multi-drug resistant bacteria.

The second UCMR Researcher who will be funded by JPIAMR over the coming three years, is Fredrik Almqvist, Department of Chemistry, who is part of a research consortium which will develop new tolerans inhibitors (MTI:s) against MDR/XDR tuberculosis. In total both researchers will receive SEK 3,1 million each.

More information:

Website of The European Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)

Website of Vasili Hauryliuk:

Website of Fredrik Almqvist:

Publication of the decision on the website of the Swedish Research Council:

(Text: Eva-Maria Diehl, Picture: Mattias Pettersson)

Emmanuelle Charpentier took the Nobel Prize in Chemistry

Emmanuelle has been awarded jointly with Jennifer Doudna the 2020 Nobel Prize in Chemistry for discovering the groundbreaking CRISPR-Cas9 gene editing technology. She is a former group leader at MIMS, honorary doctor at Umeå University and former visiting professor at UCMR.

Movie by Knut and Alice Wallenberg Foundation (

Battling antibiotic resistance

movie by Knut and Alice Wallenberg Foundation, with participation of scientists from MIMS and UCMR:
Or watch the original movie on:

Research about infectious diseases:

Oliver Billker in movie of Knut and Alice Wallenberg Foundation:
Or watch the original movie on:

footer all slides 2014-02-06

Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.